Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Japan companies hog the spotlight as hedge funds tout their top Asia picks



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Japan companies hog the spotlight as hedge funds tout their top Asia picks</title></head><body>

By Summer Zhen and Xie Yu

HONG KONG, May 24 (Reuters) -Japanese stocks were in focus at a hedge fund conference this week, accounting for most of the top Asia investment ideas as asset managers highlighted Japan Inc's efforts to improve capital efficiency as well as the record run for Tokyo shares.

At the annual Sohn Hong Kong Investment Leaders Conference which invites 14 funds to pitch their top investment ideas, Japanese companies in outsourcing, robotics and the drug sector were in favour. Only two funds pitched ideas on Chinese stocks, down from seven in 2023.

The biggest opportunities in the world's third-largest economy are in companies with "improving stories" or are bolstering corporate governance, rather than firms that are already excellent, according to David Mitchinson, founding partner at London-based Zennor Asset Management.

Mitchinson recommends Transcosmos 9715.T which provides outsourcing services and is likely to benefit from Japan's tight labour market. The firm's growth has slowed but it has shown willingness to improve capital management such as its plan to cancel treasury shares, he added.

While Japan has been bolstering governance for at least a decade, the effort got a big shot in the arm last year when the Tokyo Stock Exchange called on companies to improve capital efficiency. The bourse now publishes a monthly list of firms that have voluntarily disclosed plans to improve their use of capital.

Also helped by a weak yen, the benchmark Nikkei N225.T has surged 50% since the beginning of 2023, hitting a record high in February this year.

Japan's government continues to raise the bar for management, so "investors who engage with Japanese companies have a lot higher chance of winning than ever before," Seth Fischer, founder of activist fund Oasis Management, said in an interview ahead of the conference.

The fund sees upside potential for Kobayashi Pharmaceutical 4967.T, a drugmaker which recently recalled a health supplement after five deaths possibly linked to the product. Fischer told the conference the stock could climb if there was improved crisis management or if it went private.

Oasis could step in if there was no "self-improvement", he said, without disclosing if Oasis has shares in Kobayashi.

Hong Kong's Tybourne Capital Management said it is betting that Samsung Electronics 005930.KS can grab global memory chip market share from rival SK Hynix 000660.KS, which has much production capacity in China that it might not be able to make full use of amid geopolitical tensions.

CloudAlpha Capital Management, also from Hong Kong, is bullish on South Korea's HD Hyundai Electric 267260.KS, citing AI-linked demand for electricity equipment.



Reporting by Summer Zhen and Xie Yu; Editing by Edwina Gibbs

</body></html>

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.